Kolodziejczyk P, Garnier-Suillerot A
Laboratoire de Chimie Bioinorganique (UA CNRS 198), Université Paris-Nord, Bobigny, France.
Biochim Biophys Acta. 1987 Dec 7;926(3):249-57. doi: 10.1016/0304-4165(87)90210-8.
The interaction of mitoxantrone, ametantrone and their Pd(II) complexes with DNA have been studied using absorption and circular dichroism spectroscopy. We have shown that mitoxantrone forms with Pd(II) a complex in which two Pd(II) ions are bound to two molecules of drug (D1 and D2). One Pd(II) ion is bound to the two nitrogens of the side chain on C-5 of molecule D1 and to the two nitrogens of the side chain on C-5 of molecule D2, whereas the second Pd(II) ion is bound to the nitrogens of the side chain on C-8 of molecule D1 and of molecule D2. The same complex is formed between Pd(II) and ametantrone. The stability constants for these complexes are, respectively, beta M = (1.4 +/- 0.5).10(19) and beta A = (2.5 +/- 0.5).10(18). They display antitumor activity against P 388 leukemia which compares with that of the free drugs. Interactions of the free drugs with DNA have been studied. Mitoxantrone and ametantrone are not optically active by themselves. However, through interaction with DNA, there is an induction of optical activity within the electronic transitions of both drugs. At a nucleotide/drug molar ratio lower than about 5 a CD signal of the couplet type is observed, suggesting that there is a coupling between the pi----pi transitions of the molecules of drugs intercalated between the base pairs. This coupling disappears when the molar ratio is increased. The interactions of the Pd(II) complexes with DNA do not give rise to induction of optical activity within the electronic transition of the drugs, indicating that the presence of the metal ion prevents the intercalation of the drugs between the base pairs.
利用吸收光谱和圆二色光谱研究了米托蒽醌、氨甲蒽醌及其钯(II)配合物与DNA的相互作用。我们已经表明,米托蒽醌与钯(II)形成一种配合物,其中两个钯(II)离子与两个药物分子(D1和D2)结合。一个钯(II)离子与分子D1的C-5位侧链上的两个氮原子以及分子D2的C-5位侧链上的两个氮原子结合,而第二个钯(II)离子与分子D1和分子D2的C-8位侧链上的氮原子结合。钯(II)与氨甲蒽醌之间形成相同的配合物。这些配合物的稳定常数分别为βM =(1.4±0.5).10(19)和βA =(2.5±0.5).10(18)。它们对P 388白血病显示出抗肿瘤活性,与游离药物的活性相当。已经研究了游离药物与DNA的相互作用。米托蒽醌和氨甲蒽醌本身没有光学活性。然而,通过与DNA相互作用,两种药物的电子跃迁中都有光学活性的诱导。在核苷酸/药物摩尔比低于约5时,观察到偶合型的圆二色信号,表明插入碱基对之间的药物分子的π→π跃迁之间存在偶合。当摩尔比增加时,这种偶合消失。钯(II)配合物与DNA的相互作用在药物的电子跃迁中不会引起光学活性的诱导,这表明金属离子的存在阻止了药物插入碱基对之间。